Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AbundRX vs TRT Nation

AbundRX
Graded #181

Higher grade

vs+3.499999999999993
TRT Nation
Graded #260

Lower grade

The verdict

AbundRX takes it — 66.6/100 to 63.1/100.

AbundRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AbundRX (Abundant Wellness) is an online medical weight-care platform connecting patients with licensed clinicians for compounded GLP-1 treatment.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAbundRX +10
67
57
Dose & formulationAbundRX +4
64
60
Clinical oversightAbundRX +2
79
77
Labs & monitoringTRT Nation +9
53
62
FulfillmentAbundRX +9
74
65
Contract termsEven
55
55
AbundRX · left barTRT Nation · right bar

The numbers

MetricAbundRXTRT Nation
WeighScore66.6/10063.1/100
GradeCC
Scorecard rank#181#260
Semaglutide$179/mo (compounded)Not disclosed
Tirzepatide$279/mo (compounded)$219/mo
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
AbundRX

Graded #181 · C

Strengths

  • Two clear compounded GLP-1 pathways with transparent pricing — semaglutide $179/mo and tirzepatide $279/mo
  • Fast, free shipping and a simple few-minute online health assessment
  • Provider-guided care connecting patients with licensed US clinicians
  • Publishes Terms, Privacy, and Refund policies

Where it loses points

  • Claims LegitScript certification in text but displays no verifiable seal or listing
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Compounding pharmacy not named; no HIPAA notice found; state availability not published
  • Heavily hedged marketing language ('may include', 'helping connect patients') — reads like a lead-generation platform
TRT Nation

Graded #260 · C

Strengths

  • Flat $219/mo tirzepatide regardless of dose escalation
  • Tirzepatide compounded with B12 to reduce nausea
  • Flat plan includes unlimited virtual provider visits
  • Fully online intake-to-delivery process
  • Compounded from licensed US pharmacies

Where it loses points

  • Weight loss is secondary to core TRT business
  • Specific pharmacy partner and 503A status not disclosed
  • Compounded only; not FDA-approved formulations
  • State licensing list not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard